Tang Xing
Overview
Explore the profile of Tang Xing including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhai Y, Hui Y, Jiang Z, Ding L, Cheng J, Xing T, et al.
Front Med (Lausanne)
. 2025 Jan;
11:1478073.
PMID: 39748922
Background: Neurodermatitis is a chronic skin condition characterized by intense itching and skin thickening due to neurological dysfunction. Its persistent nature poses a challenge to effective treatment, significantly impacting patients'...
2.
Yichen W, Shiyi W, Zhengyan W, Wenling C, Zhihao X, Xing T, et al.
J Tradit Chin Med
. 2024 Jan;
44(1):163-171.
PMID: 38213251
Objective: To evaluate the efficacy and safety of Zhumian Tang formula granules combined with eszopiclone for treating poor sleep quality. Methods: This multi-center, dynamic block-randomized, parallel-group superiority clinical trial included...
3.
Guo J, Wang J, Cai C, Xu J, Yu H, Xu H, et al.
AAPS PharmSciTech
. 2015 Jan;
16(4):973-85.
PMID: 25609378
Our previous studies revealed that the PLGA-based particulate systems loaded with cucurbitacin showed limited anti-melanoma efficiency in xenograft animal models after intratumoral injection, which was due to the undesirable initial...
4.
Jianbo G, Xue L, Hongdan Y, Zhaohui T, Xing T, Chenchen C, et al.
J Pharm Sci
. 2013 Jun;
102(8):2550-63.
PMID: 23729371
A dilemma for current cancer therapy is surgical injury in addition to the toxicities and inefficiencies of systemic chemotherapy. Meanwhile, localized therapies have become a noticeable strategy. In this study,...
5.
Jijun F, Lishuang X, Xiaoli W, Shu Z, Xiaoguang T, Xingna Z, et al.
Drug Dev Ind Pharm
. 2011 Mar;
37(8):934-44.
PMID: 21417606
Using a mixture of Eudragit EPO and polyvinylpyrrolidone/vinyl acetate copolymer (PVP/VA) (Kollidon VA64) as carriers, a nimodipine solid dispersion (NM-SD) was prepared by hot-melt extrusion (HME) to achieve high dissolution....
6.
Jijun F, Lishuang X, Xiaoguang T, Min S, Mingming Z, Haibing H, et al.
J Pharm Sci
. 2011 Mar;
100(5):1643-7.
PMID: 21374603
Nimodipine (NM) solid dispersions (SD) were prepared by hot-melt extrusion with polyvinylpyrrolidone/vinyl acetate copolymer (PVP-VA; Kollidon VA64) as the carrier, then the extrudate was stored at different temperatures (20°C, 40°C,...
7.
Lixin W, Haibing H, Xing T, Ruiying S, Dawei C
Int J Pharm
. 2006 Jul;
323(1-2):161-7.
PMID: 16828998
Lipid microspheres (LM) have recently been used as intravenous (i.v.) carriers for drugs, which are sufficiently soluble in oil. However, in the case of norcantharidin (NCTD), which is poorly soluble...